ArticleBMC medical imaging2025
MCAUnet: a deep learning framework for automated quantification of body composition in liver cirrhosis patients.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional methods for measuring body composition in CT scans rely on labor-intensive manual delineation, which is time-consuming and imprecise. This study proposes a deep learning-driven framework, MCAUnet, for accurate and automated quantification of body composition and comprehensive survival analysis in cirrhotic patients. A total of 11,362 L3-level lumbar CT slices were collected to train and validate the segmentation model. The proposed model incorporates an attention mechanism from the channel perspective, enabling adaptive fusion of critical channel features. Experimental results demonstrate that our approach achieves an average Dice coefficient of 0.952 for visceral fat segmentation, significantly outperforming existing segmentation models. Based on the quantified body composition, sarcopenic visceral obesity (SVO) was defined, and an association model was developed to analyze the relationship between SVO and survival rates in cirrhotic patients. The study revealed that 3-year and 5-year survival rates of SVO patients were significantly lower than those of non-SVO patients. Regression analysis further validated the strong correlation between SVO and mortality in cirrhotic patients. In summary, the MCAUnet framework provides a novel, precise, and automated tool for body composition quantification and survival analysis in cirrhotic patients, offering potential support for clinical decision-making and personalized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.